Search

everythinglearnresearchcommunity

for

Search:↓

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Trichoscopy is effective in diagnosing trichotillomania by showing specific hair patterns.

A woman's small ovarian tumor causing high androgen levels was missed by several scans but found during surgery.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Trichoscopy is crucial for accurately diagnosing fibrosing alopecia in pattern distribution.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Certain dietary supplements can improve hair density and are well-tolerated for treating androgenetic alopecia.

Ovarian hyperthecosis caused high testosterone and virilization symptoms in a 60-year-old woman, which improved after surgery.

Early diagnosis of alopecia frontal fibrosante is crucial, but treatment remains controversial and varies.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

The higher dose supplement was more effective in treating female hair loss.

Eating a balanced diet with specific nutrients can help manage menopause symptoms and prevent related health issues.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

A 73-year-old woman's unusual hair loss and growth led to the discovery of a rare condition causing too much testosterone, which improved after her ovaries were removed.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.